Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIOB)

190.75
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
134.00
Today|||52-Week Range
190.75
+4.15%
Year-to-Date
New Strong Sell Stocks for February 17th
Feb 17 / Zacks.com - Paid Partner Content
13-F Summary: Who Bought And Sold What In The Fourth Quarter
Feb 15 / Investing Channel - Paid Partner Content
BlueCrest Capital Management Ltd Buys Waste Connections, Petroleo Brasileiro SA Petro...
Feb 16 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close190.75
Today’s openn.a.
Day’s range-- - --
Volume17
Average volume (3 months)714
Market cap$977.0M
Dividend yield--
Data as of 02/16/2017

Growth & Valuation

Earnings growth (last year)+26.23%
Earnings growth (this year)-21.20%
Earnings growth (next 5 years)-4.24%
Revenue growth (last year)-7.15%
P/E ratio57.3
Price/Sales2.02
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
AXDXAccelerate Diagnosti...+1.05+4.54%
PACBPacific Biosciences ...-0.16-3.00%
HBIOHarvard Bioscience I...-0.05-1.61%
ROKARoka Bioscience Inc+0.07+1.48%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateFebruary 24, 2017
EPS forecast (this quarter)$1.03
Annual revenue (last year)$2.0B
Annual profit (last year)$113.1M
Net profit margin5.60%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts

Chart unavailable

Search for Jobs